Bank of America’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-541,875
| Closed | -$12.5M | – | 7113 |
|
|
2020
Q4 | $12.5M | Buy |
541,875
+59,074
| +12% | +$1.36M | ﹤0.01% | 1996 |
|
|
2020
Q3 | $4.92M | Buy |
482,801
+227,246
| +89% | +$2.31M | ﹤0.01% | 2580 |
|
|
2020
Q2 | $3.81M | Sell |
255,555
-3,194
| -1% | -$47.6K | ﹤0.01% | 2754 |
|
|
2020
Q1 | $3.15M | Sell |
258,749
-18,532
| -7% | -$226K | ﹤0.01% | 2763 |
|
|
2019
Q4 | $4.39M | Buy |
277,281
+36,821
| +15% | +$583K | ﹤0.01% | 2885 |
|
|
2019
Q3 | $2.95M | Buy |
240,460
+240,260
| +120,130% | +$2.95M | ﹤0.01% | 3143 |
|
|
2019
Q2 | $3K | Buy |
+200
| New | +$3K | ﹤0.01% | 6132 |
|